Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Deferasirox
Drug ID BADD_D00594
Description Deferasirox is an iron chelator and the first oral medication FDA approved for chronic iron overload in patients receiving long term blood transfusions.
Indications and Usage For the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older.
Marketing Status Prescription
ATC Code V03AC03
DrugBank ID DB01609
KEGG ID D03669
MeSH ID D000077588
PubChem ID 214348
TTD Drug ID D0Q5UQ
NDC Product Code 62332-412; 43598-856; 57664-769; 62332-411; 62756-569; 0078-0469; 70771-1411; 66039-871; 69097-550; 70771-1471; 72647-371; 62512-0078; 68462-494; 69539-021; 31722-012; 69097-391; 57664-770; 58032-2017; 69539-200; 63278-1070; 72647-372; 46708-324; 69452-159; 62332-410; 53104-7713; 72606-014; 11722-040; 69097-570; 43598-851; 62332-324; 67877-549; 69539-022; 66022-0301; 0591-3853; 45963-456; 14501-0049; 46708-410; 62332-325; 46708-879; 72606-013; 62756-570; 69238-1486; 43598-854; 65085-0063; 62332-326; 69238-1704; 70710-1011; 59285-010; 46708-326; 70710-1012; 59651-419; 16714-995; 69539-199; 72205-076; 65727-037; 74436-0323; 57664-768; 68462-495; 46708-325; 69452-160; 0078-0713; 65015-738; 16714-993; 69097-393; 69097-560; 0078-0470; 31722-013; 69539-074; 43598-853; 70700-269; 70771-1409; 49706-2103; 70710-1277; 43598-855; 0078-0468; 65372-1164; 16714-994; 43598-852; 45963-455; 46708-412; 0078-0727; 70771-1472; 72647-373; 68462-496; 67877-553; 69238-1703; 45963-454; 69452-161; 0078-0654; 62756-568; 70771-1473; 69539-023; 67877-550; 0078-0720; 70710-1275; 31722-011; 72606-015; 70771-1410; 69539-075; 67877-551; 70710-1013; 67877-554; 72205-075; 0078-0656; 70700-270; 69238-1702; 0078-0655; 46708-411; 69097-392; 69539-073; 69238-1487; 67877-552; 70700-271; 70710-1276; 69238-1488
Synonyms Deferasirox | 4-(3,5-Bis-(2-hydroxyphenyl)-(1,2,4)-triazol-1-yl)benzoic acid | ICL 670A | ICL-670A | ICL670A | ICL-670 | ICL670 | ICL 670 | Exjade
Chemical Information
Molecular Formula C21H15N3O4
CAS Registry Number 201530-41-8
SMILES C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.0010.230331%Not Available
Abdominal distension07.01.04.0010.075805%
Abdominal pain07.01.05.0020.460663%
Abdominal pain lower07.01.05.010--Not Available
Abdominal pain upper07.01.05.0030.338208%
Abdominal tenderness07.01.05.0040.020409%Not Available
Abnormal faeces07.01.03.0010.005831%Not Available
Abortion spontaneous18.01.04.001--Not Available
Acidosis14.01.03.0020.008747%
Acidosis hyperchloraemic14.01.01.0070.011662%Not Available
Acute hepatic failure09.01.03.0010.004564%Not Available
Acute leukaemia01.10.02.001; 16.01.02.0010.006085%Not Available
Acute myeloid leukaemia01.10.05.001; 16.01.05.0010.032705%Not Available
Acute myocardial infarction02.02.02.001; 24.04.04.001--Not Available
Acute respiratory failure14.01.04.004; 22.02.06.001--Not Available
Adenocarcinoma16.16.01.0040.001521%Not Available
Ageusia07.14.03.003; 17.02.07.001--Not Available
Aggression19.05.01.001--Not Available
Agitation17.02.05.012; 19.06.02.001--
Agranulocytosis01.02.03.001--Not Available
Alanine aminotransferase increased13.03.01.0030.119539%
Albuminuria20.02.01.0010.011662%Not Available
Alopecia23.02.02.001--
Altered state of consciousness17.02.04.001; 19.07.01.0030.020409%Not Available
Alveolar proteinosis22.01.02.0090.005831%Not Available
Amaurosis fugax06.02.02.005; 17.08.04.002; 24.04.06.0060.005831%Not Available
Aminoaciduria03.08.04.003; 14.14.04.003; 20.02.01.0240.005831%Not Available
Ammonia increased13.03.01.0230.004564%Not Available
Amnesia17.03.02.001; 19.20.01.001--
Anaemia01.03.02.0010.250741%
The 1th Page    1 2 3 4 5    Next   Last    Total 28 Pages